Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

may preserve tissue function despite defective

Inhibiting mechanistic target of rapamycin (mTOR) may protect several tissues by accelerating disposal of damaged proteins outside despite blocked . Benefit without extra destruction of the relevant proteins would refute this mechanism.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionWhole body

Ageing mechanism

Main connectionLoss of proteostasis

Direction

Kind of knowledge gap

The question is designed to try to disprove the leading explanation.Adversarial gap

A double ring marks the main placement where a group contains several values.

Lens
Ubiquitin dependent protein disposal
Goal
Перечень причинно самостоятельных идей серебряных пуль для продления жизни
Competing hypotheses
4
Published
2026-09-30
As a hypothesis
8 / 10Clarity of mechanism
7 / 10Few extra conditions
9 / 10Completeness of the answer
5 / 10Novelty of the idea
9 / 10Few new entities
8 / 10Decisive experiment
4 / 10Silver-bullet potential
4 / 10Support from research
Poster: Protein disposal preserves tissue function
PosterOpen the sheet full size2026-10-01

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Enzyme

    A protein whose suppression reduces excessive in the proposed pathway

    Where this hypothesis actsAcross multiple tissues with persistent defective

    Hypotheses on this target 4
    mTORInhibition. Hypotheses on this target 44Activation. Hypotheses on this target 0Lower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Replacement. Hypotheses on this target 0Protection from degradation. Hypotheses on this target 0Cofactor removal. Hypotheses on this target 0Synthesis suppression. Hypotheses on this target 0Function preservation. Hypotheses on this target 0
    • Inhibition4
    • Activation
    • Lower level
    • Higher level
    • Replacement
    • Protection from degradation
    • Cofactor removal
    • Synthesis suppression
    • Function preservation

    What is proposed

    Inhibition

    Suppress to increase degradation of damaged proteins

    With whatNot stated in the record

    HowNot stated in the record

    Possible result

    Possible sustained functional benefit through clearance of damaged proteins outside

    From the recordПодавление mTOR повышает убиквитинирование и протеасомное разрушение повреждённых долгоживущих белков вне митохондрий.

  2. Metabolism and energy

    Ubiquitin-dependent proteasomal degradation

    The breakdown of ubiquitin-marked proteins by the

    Where this hypothesis actsDamaged outside , across multiple tissues with defective

    Hypotheses on this target 1
    Ubiquitin-dependent proteasomal degradationInhibition. Hypotheses on this target 0Activation. Hypotheses on this target 11Function preservation. Hypotheses on this target 0Supplementation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition
    • Activation1
    • Function preservation
    • Supplementation
    • Feedback restoration
    • Direct measurement

    What is proposed

    Activation

    Increase ubiquitin-dependent degradation of damaged proteins

    With whatNot stated in the record

    HowSuppress ; the or set responsible for the additional degradation remains to be identified

    Possible result

    Possible restoration of and contractile function despite persistent defective

    From the recordНакопление повреждённых белков служит причинным субстратом, а протеасомный поток является необходимым посредником.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαmTOR. Hypotheses on this target 4mTOR
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradation
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Several parts of an aging body might benefit from removing the same kind of accumulated damage. The unexpected move is to propose that clearing damaged proteins outside , the cell structures that convert nutrients into usable energy, could preserve tissue function even when removal of damaged remains defective. This is a hypothesis generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. Suppressing is proposed to increase disposal tags on damaged, outside .
  2. Those tags are proposed to direct more of the damaged proteins into for destruction.
  3. Faster destruction is proposed to reduce the accumulated damaged proteins while mitochondrial removal remains defective.
  4. Removing the damaged proteins is proposed to restore chemical reactions and contraction in several tissues.
  5. Restored tissue function is predicted to produce lasting benefits beyond delaying a single tumor-related cause of death.
A picture for it

A workshop could regain useful space by clearing broken tools even while its service for removing broken generators remains out of action.

Where the picture breaks: The picture assumes that broken tools obstruct work and that removing them restores it. The biological proposal must establish both points for the particular damaged proteins, and removal alone does not explain how working proteins replace them.

  1. Master questionstep 01 of 04

    Aging processes may reinforce one another, so targeting a shared cause could benefit several body systems at once.

    Rests on: The goal takes the possibility of a shared, treatable cause as the basis for generating life-extension ideas.

    Assumption

    The supplied goal assumes that a shared causal link could be targeted for benefits across systems; it does not establish a particular link or intervention.

  2. Goal pillarstep 02 of 04

    The intended output is a set of life-extension ideas that act through distinct causal routes.

    Rests on: The master question explicitly requests ideas for shared targets that could benefit several aging systems.

    Stated in the chain
  3. Gap questionstep 03 of 04

    Life extension from suppressing might persist after disabling , the selective removal of , even if damage continues to amplify between body systems and the entire survival benefit comes from delaying one cause of death.

    Rests on: The preceding goal calls for distinct causal explanations, but does not introduce this treatment, its proposed mitochondrial route, or the conditions used to challenge that route.

    Leap

    The supplied chain does not explain the selection of suppression and from the broader goal. The screened sources do not establish the combined situation of continued life extension, disabled , unchanged amplification of damage between systems, and benefit attributable to one cause of death.

  4. Hypothesisstep 04 of 04

    Suppressing is proposed to increase , the attachment of a protein tag that can direct disposal, and destruction of damaged, by the , a cellular protein-cutting machine. Removing these proteins outside is proposed to restore , proteins that speed up chemical reactions, and the machinery that produces contraction in several tissues despite defective .S3S6S7

    Rests on: The gap question leaves room for a route that works despite defective mitochondrial removal. S3, in FASEB BioAdvances in 2024, reports increased destruction of , a protein that regulates the persistence of cellular messages, after in infected immune cells; it does not establish clearance of damaged, or benefits across tissues. S6, in The Journal of Biological Chemistry in 2024, describes disposal of irreversibly damaged proteins, without establishing this treatment or its proposed benefits. S7, in the same journal in 2022, reports longer life and greater resistance to damaging conditions after increasing activity in roundworms, alongside reduced offspring production; it does not establish the proposed route in old animals with defective .

    Supported by literature

What is carried, and what is not. The screened literature provides partial backing for two broad parts of the proposed mechanism: altered protein disposal after suppression and protection associated with greater activity. It does not establish the sequence end to end; S5, a 2023 review in Cells, also reports that treatment reduced elevated expression of components in genetically altered mouse muscle, which challenges a simple expectation of uniformly increased disposal but does not measure the specific damaged-protein removal proposed here.S5

Where the reasoning is carried by something unstated · 2
  • Master question. The supplied goal assumes that a shared causal link could be targeted for benefits across systems; it does not establish a particular link or intervention.
  • Gap question. The supplied chain does not explain the selection of suppression and from the broader goal. The screened sources do not establish the combined situation of continued life extension, disabled , unchanged amplification of damage between systems, and benefit attributable to one cause of death. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • More ubiquitin tags could be mistaken for faster destruction of the tagged proteins. Tag accumulation alone does not show that disposal has been completed. What closes it: The proposed , a chemically distinguishable marker used to follow existing proteins, must track the disappearance of the relevant previously labeled damaged proteins over time. Tag measurements must be interpreted alongside that removal rate.
  • Loss of protection after broadly suppressing could be attributed to removal of the proposed protective route when it instead reflects toxicity from disrupting ordinary protein disposal. What closes it: The specification requires identifying the or protein targets responsible for the treatment-induced increase before testing necessity. The intervention must selectively remove that increase, preserve suppression and the specified changes in production of cellular messages, and distinguish loss of protection from damage caused by the intervention itself; independent restoration of disposal must return protection.
  • Longer survival could be credited to protection across tissues even if treatment only delays a fatal tumor, leaving the central distinction in the gap question unresolved. What closes it: Survival must be assessed alongside sustained function in several tissues and the causes of death. The supplied specification predicts such functional benefit but does not name the tissue measurements, observation period, or criteria that would distinguish it from postponing one fatal disease.

What would make this wrong. The hypothesis would be contradicted if functional protection persisted despite verified absence of the treatment-induced increase in destruction of the relevant damaged proteins. That observation would break the claimed requirement for extra protein disposal even if suppression still improved survival or tissue function.

What it would change. If the proposed sequence held, damaged-protein accumulation would become a candidate shared cause whose removal preserves several tissues despite defective mitochondrial removal. Work on a life-extending shared target would then have to distinguish this disposal route from mitochondrial removal and from postponement of a single fatal disease. Even a successful functional test would not by itself establish longer life, reduced amplification of damage between organs, or benefits in humans.

Sources read · 10

4 literature searches, 7 full texts, 3 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Background

Reversing Autophagy Inhibition Ameliorates Neurodegeneration in Hereditary Spastic Paraplegia Caused by a Degradation-Resistant SPAST Mutation. · Movement disorders : official journal of the Movement Disorder Society · 2026

“Rapamycin restored autophagy, decreased p62 levels, and reduced cell death.”

Does not settle: It does not establish mTOR inhibition increases ubiquitination or proteasomal degradation, preserves function despite defective mitophagy, restores enzymes or contractile machinery across tissues, or that proteasomal flux is a necessary mediator of sustained functional benefit.

S2Contradicts itAbstract only

HSP70 promotes amino acid-dependent mTORC1 signaling by mediating CHIP-induced NPRL2 ubiquitination and degradation. · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024

“Taken together, these results demonstrated that HSP70 is a novel activator of mTORC1 through mediating CHIP-induced ubiquitination and degradation of NPRL2.”

Does not settle: Источник не исследует подавление mTOR, повреждённые долгоживущие белки вне митохондрий, дефект митофагии, восстановление функций тканей или необходимость протеасомного потока для такой пользы.

S3Partly answers it

Tristetraprolin mediates immune evasion of mycobacterial infection in macrophages. · FASEB bioAdvances · 2024

“These results indicate that inhibition of the mTOR signaling pathway promotes TTP degradation through a ubiquitin/proteinase‐dependent mechanism.”

Does not settle: The source studies BCG-infected macrophages and TTP. It does not establish removal of damaged long-lived proteins, preservation of enzyme or contractile function across tissues, persistent mitophagy defects, or a benefit beyond infection-related outcomes.

S4BackgroundAbstract only

Dysfunction of Avo3, an essential component of target of rapamycin complex 2, induces ubiquitin-proteasome-dependent downregulation of Avo2 in Saccharomyces cerevisiae. · Biochemical and biophysical research communications · 2024

“Here we report a functional interplay between the UPS and TORC2 in Saccharomyces cerevisiae.”

Does not settle: Источник не изучает подавление mTOR, повреждённые долгоживущие белки вне митохондрий, митофагию, функцию ферментов или сократительного аппарата, несколько тканей либо устойчивую функциональную пользу.

S5Contradicts it

Age-Related Dysfunction in Proteostasis and Cellular Quality Control in the Development of Sarcopenia. · Cells · 2023

“Skeletal muscle from TSC1-knockout mice exhibit greater expression of several atrogenes and components of the 26S proteasome that is reversed by acute 3-day treatment with rapamycin.”

Does not settle: Остаются открытыми убиквитинирование и разрушение повреждённых долгоживущих белков вне митохондрий, сохранение дефекта митофагии, восстановление функций в нескольких тканях, причинная роль накопления белков, необходимость протеасомного потока и долговременная функциональная польза.

S6Background

Redox regulation of proteostasis. · The Journal of biological chemistry · 2024

“cells must eliminate oxidized proteins that are irreversibly damaged by targeting them for degradation either by the proteasome or by the autophagy/lysosomal machinery”

Does not settle: The source does not establish mTOR suppression, ubiquitination or proteasomal flux as a necessary mediator, clearance of long-lived non-mitochondrial proteins, persistent mitophagy defects, restoration of enzyme or contractile function across tissues, or durable organismal functional benefit.

S7Partly answers it

Hyperactivation of the proteasome in Caenorhabditis elegans protects against proteotoxic stress and extends lifespan. · The Journal of biological chemistry · 2022

“We determined these nematodes showed a significantly increased lifespan and substantial resistance to oxidative and proteotoxic stress but a significant decrease in fecundity.”

Does not settle: This Caenorhabditis elegans proteasome-gate mutation study does not test mTOR inhibition, defective mitophagy, damaged long-lived proteins outside mitochondria, restoration of enzymes or contractile machinery across tissues, or whether proteasomal flux is necessary for those outcomes.

S8Partly answers it

HSP70 Inhibition Leads to the Activation of Proteasomal System under Mild Hyperthermia Conditions in Young and Senescent Fibroblasts. · Oxidative medicine and cellular longevity · 2020

“However, when HSP70 expression was inhibited, the proteasome activity was found to increase to maintain protein homeostasis.”

Does not settle: This source does not test mTOR suppression, ubiquitination, mitophagy defects, removal of damaged long-lived proteins, restoration of enzyme or contractile function, causality of protein accumulation, proteasome necessity, multiple tissues, or sustained organism-level functional benefit.

S9BackgroundAbstract only

UVB-Induced Senescence of Human Dermal Fibroblasts Involves Impairment of Proteasome and Enhanced Autophagic Activity. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2017

“We provide evidence that the inhibition of proteasomal degradation of damaged proteins and the activation of autophagosome formation are early events in UVB-induced senescence of HDFs, dependent on UVB-induced accumulation of reactive oxygen species.”

Does not settle: Источник не исследует подавление mTOR, убиквитинирование, митофагию, восстановление функции ферментов или сократительного аппарата, необходимость протеасомного потока и пользу в нескольких тканях.

S10Background

The yeast mitophagy receptor Atg32 is ubiquitinated and degraded by the proteasome. · PloS one · 2020

“Atg32 turnover can be prevented by inhibition of the proteasome”

Does not settle: Источник описывает протеасомный распад рецептора митофагии Atg32 у дрожжей. Он не устанавливает влияние подавления mTOR на повреждённые долгоживущие белки вне митохондрий, восстановление функций тканей, сохранение дефекта митофагии или необходимость протеасомного потока для такой пользы.

The gap this hypothesis explains

Two live hypotheses pull in opposite directions here, and the field has not chosen between them.

Does blocking a growth-control protein still extend mouse life when damaged cell powerhouses cannot be cleared?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Сохранится ли продление жизни при после выключения предполагаемого , , если межсистемное усиление повреждений останется прежним, а весь выигрыш объяснит отсрочка одной причины смерти?

What this question is asking

The question asks whether removing damaged energy-producing structures inside cells is necessary for a treatment to extend mouse life. It concerns suppression of mammalian target of (), a protein involved in controlling cell growth, after disabling , the process that removes those structures. The relevant comparison is whether suppression still increases remaining lifespan relative to no suppression when this removal process is disabled, compared with when it remains available. The question also considers a conditional explanation: damage in different body systems might continue to worsen other systems' damage, while the entire survival benefit comes from postponing just one cause of death.

What the terms mean
Mammalian target of rapamycin (mTOR)
A protein involved in controlling cell growth. Suppression means reducing its activity; the question asks whether the resulting lifespan effect requires removal of damaged cellular powerhouses.
Mitochondria
Structures inside cells involved in producing usable energy, described here as cellular powerhouses. Their removal is the proposed link between treatment and longer life.
Mitophagy
The cellular process that removes , including damaged ones. The question treats it as a possible necessary step in the lifespan effect, which the supplied sources do not establish.
Autophagy
The broader cellular process for removing and recycling material within cells. is the -focused form; a finding about the broader process does not automatically establish the particular role of .
Mediator and mediation
A is an intermediate process through which an intervention causes an outcome. Here, would mean that suppression of extends life through its effect on , rather than the two simply being associated.
Intersystem damage amplification
The proposed process in which damage in one body system worsens damage in another. Its persistence during treatment is a condition considered by the question, not a finding established by the supplied sources.
Rapamycin
The treatment evaluated in the mouse lifespan findings quoted in S2. Those findings describe survival responses but do not establish the proposed role of .
Corylin
The compound studied in S3. The supplied quotation reports a lifespan benefit in female mice without a comparable benefit in males.
Median lifespan
The time by which half of a studied group has died. It summarizes survival and does not identify which causes of death changed.
Survival rate at a stated age
The proportion of a group still alive at that age. S3 reports a comparison at 125 weeks; the supplied quotation does not give the underlying proportions.
Mouse strain
A mouse breeding line with a particular inherited background. S2 reports that strain influences the size of the lifespan response.
Kisspeptin-10
The molecule used in S5 to stimulate cellular removal processes. The supplied quotation describes a route independent of , so it does not establish of a treatment that suppresses .
Cellular signaling
Processes through which activity in one part of a cell changes activity elsewhere in it. A signaling connection alone does not establish an effect on whole-animal lifespan.
Human neuronal cell line
Human cells maintained in laboratory culture and used to study nerve-cell processes. Findings in these cells do not by themselves establish survival effects in an animal.
Hippocampus and cultured hippocampal tissue
The hippocampus is a brain region. Cultured hippocampal tissue is tissue from that region maintained outside the animal; S5 includes this preparation alongside cell cultures and aging rats.
What the question takes for granted
Premise could not be checked
suppression is associated with longer mouse survival, is its proposed cellular , and the survival gain might occur with unchanged intersystem damage amplification because only one cause of death is delayed.

The proposed explanation places removal of damaged cellular powerhouses between blocking a growth-control protein and longer life. It contrasts protection across several body systems with a scenario in which damage still spreads between systems but one fatal condition occurs later. Establishing these links would distinguish a shared protective process from a narrower explanation of longer survival.

S2 reports generally favorable mouse lifespan findings for , and S3 reports longer life in female mice receiving corylin. Neither supplied quotation establishes that removal of damaged cellular structures mediates those benefits. S5 instead reports stimulation of that removal through a route independent of ; it does not establish the proposed . None of the supplied sources establishes unchanged damage amplification between systems or a survival gain fully explained by delaying one cause of death. Those last conditions are hypothetical in the question, and this background-focused selection is too limited to establish or refute the complete premise.S2S3S5

The same question asked without the part nothing read establishes:

  • Does suppressing the growth-control protein extend mouse life when removal of damaged cellular powerhouses is disabled?
  • Does longer mouse life under suppression of the growth-control protein reflect lasting benefits across several body systems or postponement of one cause of death?
What turns on the answer
  • The lifespan benefit persists Under the question's assumption that removal of damaged cellular powerhouses has been disabled, a persisting benefit would mean that this removal is not necessary for the entire survival effect. If postponement of one cause of death accounts for all of that benefit, longer life would not by itself demonstrate protection across several body systems.
  • The lifespan benefit disappears Losing the benefit would be consistent with the removal process being necessary for the survival effect in the stated conditions. That result alone would still not establish that the process protects several systems or interrupts damage spreading between them.
  • The lifespan benefit becomes smaller A smaller benefit would be consistent with the removal process contributing to, but not fully accounting for, longer survival. The remaining benefit would still need to be distinguished from the question's alternative explanation of postponing one cause of death.
Why it matters

The proposed explanation links suppression of the growth-control protein to removal of damaged cellular structures, then to lasting benefits across several body systems, and finally to longer life. Each connection matters because longer survival alone does not establish the preceding steps. Under the question's alternative explanation, postponing one fatal disease could extend life while damage elsewhere continues. Mistaking that outcome for protection across several systems would overstate what the survival findings establish.

What is already established

уровня связано с мышиной выживаемостью; уровня показано на клетках.

What would have to be true

Выигрыш оставшейся жизни должен сопровождаться устойчивой пользой нескольким системам и проверенным общим за единый .

What is missing

Не установлено, объясняет ли многосистемный выигрыш жизни; подавление отдельной смертельной может воспроизводить наблюдаемую выживаемость.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

повышает и повреждённых вне . Удаление этих белков восстанавливает работу и в нескольких тканях даже при сохраняющемся дефекте . Накопление повреждённых белков служит , а является . Эта версия предсказывает устойчивую функциональную пользу, выходящую за пределы отсрочки одной опухолевой причины смерти.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

После выключения сохраняются ускоренное разрушение заранее повреждённых и функциональная польза. Устранение именно вызванного лечением прироста отменяет пользу, хотя подавление mTOR и изменения сохраняются. Независимое восстановление возвращает защиту. Сохранение пользы при отсутствии дополнительного разрушения соответствующих белков опровергает гипотезу.

States a measurable outcome; comparing rivals needs more conditions. The text specifies observable persistence, loss, and restoration of benefit under stated conditions, plus an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Скорость разрушения белков можно измерять по и . Общее подавление токсично и не является чистой проверкой . Сначала необходимо определить или набор , обеспечивающий дополнительный поток, и лишь затем проверять его необходимость в старых животных.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

После выключения сохраняются ускоренное разрушение заранее повреждённых и функциональная польза. Устранение именно вызванного лечением прироста отменяет пользу, хотя подавление mTOR и изменения сохраняются. Независимое восстановление возвращает защиту. Сохранение пользы при отсутствии дополнительного разрушения соответствующих белков опровергает гипотезу.

  • What would separate them

    Rapamycin may extend life by changing calcium control of breathing-muscle contraction predicts: При подтверждённой блокаде сохраняет выигрыш оставшейся жизни и повышает устойчивость к повторным сокращениям. Сопоставимое подавление mTOR генетическим способом этого результата не воспроизводит. Лиганд FKBP12, сохраняющий необходимое и не подавляющий , воспроизводит оба эффекта. Избирательное устранение отменяет выигрыш при сохранённом . Сохранение пользы генетического после такого устранения опровергает гипотезу.

  • What would separate them

    Growth-signal inhibition may release a brake on protein kinase B and limit cell death predicts: После блокады сохраняются краткий ответ , уменьшение после повторной нагрузки и замедление функционального ухудшения нескольких систем. Избирательное устранение вызванного лечением ответа отменяет эти эффекты при сопоставимом . Модель, построенная по ответам на одиночные слабые нагрузки, заранее предсказывает меньший пик повреждения при их сочетании. Если защита сохраняется при устранённом ответе либо измеренный ответ усиливает повреждение, гипотеза отвергается.

  • What would separate them

    Lysosomal acidity may mimic faster mitochondrial removal predicts: Изменение сигнала объясняется независимо измеренной кислотностью и количеством ранее накопленного . После соответствующей увеличение потока исчезает; независимое отслеживание доставки и разрушения также не выявляет ускорения. При этом подавление mTOR замедляет рост опухоли даже после устранения дополнительных механизмов остальных гипотез. Длительные траектории заранее выбранных неопухолевых функций остаются прежними. Подтверждение ускоренного удаления целых независимыми методами опровергает оптическую часть гипотезы.

  • What would separate them

    Reducing ribosomal gene transcription may protect tissues by limiting genome damage predicts: При подавленной лечение уменьшает и новые разрывы в до появления функциональной пользы. Направленное удаление патологических воспроизводит защиту и уменьшает дополнительный эффект в диапазоне, свободном от . Избирательное восстановление исходного уровня при сохранённом отменяет защиту. Если лечение сохраняет функциональную и жизненную пользу при экспериментально восстановленном , эта версия отвергается.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.